微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 5.68% | 79.75% | 244.24% | 63/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.65% | -2.37% | -55.53% | 90/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.71% | 231.25% | 2373.33% | 19/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 0.15% | -97.23% | -95.25% | 101/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.16% | 7.12% | 86.98% | 91/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.69% | 19.01% | 50.89% | 89/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.12% | -5.08% | -79.3% | 86/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.41% | -1.81% | 83.39% | 73/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.95% | 18.47% | 107.75% | 86/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.42% | 46.39% | 20.34% | 97/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.18% | 55.26% | -78.58% | 87/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.51% | 15.76% | 121.29% | 75/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.49% | -3.86% | 156.7% | 100/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.97% | 8.99% | 27.63% | 109/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.76% | -16.48% | -84.03% | 101/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.76% | -10.02% | 83.78% | 86/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.59% | 3.6% | 191.01% | 89/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.89% | -43.67% | -2.2% | 102/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.91% | -14.95% | -82.8% | 71/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 5.29% | 87.59% | 111.6% | 85/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.5% | 38.12% | 58.23% | 92/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.58% | -30.7% | 47.66% | 92/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.07% | 5.94% | -62.06% | 85/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 2.82% | -70% | 55.8% | 104/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.81% | -69.11% | -20.61% | 93/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.28% | -37.19% | 125.74% | 78/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.01% | 1% | -89.26% | 76/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9.4% | -48.66% | 60.41% | 53/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.86% | 2% | 61.43% | 57/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.63% | -61.83% | 263% | 67/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1% | 2% | -94.54% | 62/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 18.31% | -31.09% | 92.53% | 27/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 9.51% | 2% | -64.21% | 15/158 | 3.86% | 南新制药 | 81.7% | 行业排名> |
| 2015-12-31 | 26.57% | 4.69% | 4.69% | 12/158 | 11.35% | 德展健康 | 29.5% | 行业排名> |
| 2014-12-31 | 25.38% | 2% | 2% | 12/158 | 12.37% | 贝达药业 | 16.78% | 行业排名> |